News
By Dennis Thompson HealthDay ReporterMONDAY, July 14, 2025 (HealthDay News) — Good news for women of a certain age: Hormone ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
A FAT jab user has revealed that after stopping the injections for eight weeks, she has now realised she is a “Mounjaro lifer ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Pointing to Ozempic as a paradigm shift, an elite rehab center is experimenting with GLP-1s to tame many forms of addiction.
Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18 ...
Weight loss medications can reduce the efficacy of oral contraceptives. What to know before taking drugs like Ozempic, ...
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
Ozempic is known take pounds off your body, but a noticeable side effect in the private area is proving otherwise for male users.
Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results